Executive Director, Asset Team Lead

Role: Executive Director, Asset Team Lead, responsible for strategic development of small molecule clinical programs in oncology and immunology/inflammation. Objectives include leveraging computational insights, defining asset strategies, and optimizing portfolio decisions to accelerate drug development. Responsibilities involve translating AI-driven data into competitive advantages, developing evidence-based narratives for clinical assets, and collaborating across clinical development, discovery, platform, and business development teams to align resources and priorities. Requirements: PhD in life sciences or related field, 10+ years in biotech/pharma with proven asset-level leadership, expertise in small molecule therapeutics for oncology and immunology, and experience using computational platforms to inform decision-making. Preferred: experience in rare diseases, strong financial acumen, and exceptional communication skills. High-value details: focus on AI-enabled drug discovery, portfolio management across oncology and immunology, and working within a cutting-edge, data-driven environment. Work setup: remote in the U.S. with periodic travel.